Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006295 |
---|---|
Receipt number | R000007425 |
Scientific Title | Phase II clinical trial of combination of personalized peptide vaccination and Juzen-taiho-to for Pancreatic cancer patients who failed standard therapy or unresectable. |
Date of disclosure of the study information | 2011/09/06 |
Last modified on | 2016/12/26 17:36:48 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/09/06 18:18:12 | ||
2 | Update | 2011/10/05 23:00:18 | Organization1 Tel1 Email1 |
|
3 | Update | 2014/04/22 11:57:11 | Recruitment status |
|
4 | Update | 2014/07/14 14:23:25 | Division name Division name Address Address TEL TEL Institute Institute Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization |
|
5 | Update | 2016/12/26 17:36:48 | Recruitment status |